Ocular Myasthenia Gravis Clinical Trial
Official title:
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
This study collects the clinical data of new-onset ocular myasthenia gravis (OMG) patients, assesses outcomes and adverse effects of different treatment options, and evaluate risk factors of conversion to generalized MG(GMG).
This is a multicenter, observational cohort trial in the real-world clinical setting recruiting new-onset OMG patients from Neurology Departments of 7 hospitals in different regions of China. Clinical manifestations, laboratory test results, chest imaging and history of thymectomy are recorded. Treatment option are determined according to the physician's judgment and preferences of the patients. Patients are followed up prospectively on regular to assess the outcomes of treatments and monitor any side effects. Peripheral blood samples are collected annually. The investigators plan to recruit a final sample of 200 patients for analysis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06342544 -
Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
|
Phase 3 | |
| Completed |
NCT05045248 -
Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
|
Phase 2 | |
| Completed |
NCT04667650 -
Ocular Mysathenia Gravis Generalization
|
||
| Recruiting |
NCT05091177 -
Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis
|
||
| Terminated |
NCT00995722 -
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
|
Phase 3 |